Please login to the form below

Not currently logged in
Email:
Password:

Sanofi Genzyme

This page shows the latest Sanofi Genzyme news and features for those working in and with pharma, biotech and healthcare.

M&F Health, 90TEN and Sanofi among big winners at Communiqué Awards

M&F Health, 90TEN and Sanofi among big winners at Communiqué Awards

Sponsored by Burson Cohn &Wolfe. Winner: See Below. by Havas Lynx for Sanofi Genzyme Regeneron. ... by Havas Lynx for Sanofi Genzyme. 20. Charity, Patient or Professional Association of the Year.

Latest news

  • Oncology drives AstraZeneca, Genzyme boosts Sanofi Oncology drives AstraZeneca, Genzyme boosts Sanofi

    Meanwhile, Sanofi released its Q1 results, and its growth beat expectations, driven in part by its rare disease arm Genzyme. ... In total, Genzyme delivered a 31% sales increase, which was helped by its monoclonal antibody Dupixent.

  • AZ says dropping MedImmune will help ‘streamline’ its R&D AZ says dropping MedImmune will help ‘streamline’ its R&D

    Nevertheless, as MedImmune has operated as a semi-independent unit within AZ – in much the same way as Genentech within Roche and Sanofi’s Genzyme – the decision raises questions about how

  • Sanofi extends growth spurt thanks to Genzyme, Dupixent Sanofi extends growth spurt thanks to Genzyme, Dupixent

    US approval of Cablivi adds to good news. Sanofi has put a long run of decline caused by patent losses in its rear view mirror, with rare disease unit Genzyme and ... There was positive news for Sanofi’s new play in rare blood disorders.

  • Havas Lynx Group scoops nine Golds at PM Society Awards Havas Lynx Group scoops nine Golds at PM Society Awards

    Meanwhile, Sanofi Genzyme and Regeneron came out on top in the pharma category, collecting five Golds and one Silver. ... Target Award for Secondary Care Advertisement: Cognite for Tillots Pharma. Innovation: Havas Lynx for Sanofi Genzyme and Regeneron.

  • Dupixent helps put Sanofi back on growth track Dupixent helps put Sanofi back on growth track

    Gains for vaccine division Sanofi Pasteur and the company’s specialty medicines division, which along with Dupixent includes Genzyme’s rare disease drugs and multiple sclerosis therapies like Aubagio (teriflunomide), contributed ... Buoyed by an 8%

More from news
Approximately 16 fully matching, plus 68 partially matching documents found.

Latest Intelligence

  • Innovation and digital health comms recognised at Communiqué Awards Innovation and digital health comms recognised at Communiqué Awards

    Innovation in Healthcare Communications. One high profile winning campaign was Havas Lynx Group’s ‘See Below’ on behalf of Sanofi Genzyme and Regeneron.

  • Trust me, I’m from pharma Trust me, I’m from pharma

    Rather than assuming anything, Sanofi Genzyme took a step back and asked patients: how can we help? ... In Sanofi Genzyme’s case, it culminated in a set of briefs that were owned by the patients living with the disease.

  • Medius Deal Watch table for February 2015 Medius Deal Watch table for February 2015

    Voyager Therapeutics/ Sanofi (Genzyme). Gene therapy - Parkinson's disease, Friedreich's ataxia and Huntington's disease.

  • Pharma deals during January 2014 Pharma deals during January 2014

    The other deal announced by Alnylam was the expansion of its deal with Sanofi (Genzyme unit_ to develop RNAi therapeutics in rare diseases. ... In 2008 Genzyme gained rights to ataluren from PTC Therapeutics at a cost of $100m.

  • Interview: Laure Thibaud, Sanofi Interview: Laure Thibaud, Sanofi

    overnight.” . The Genzyme deal, for which Thibaud was involved in the pre-acquisition stage of the agreement, as well as the company's subsequent integration into Sanofi, was particularly exciting, she ... Chris Viehbacher has said too that he was

More from intelligence
Approximately 0 fully matching, plus 7 partially matching documents found.

Latest appointments

More from appointments
Approximately 1 fully matching, plus 10 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 4 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Six Degrees Medical Consulting

For over a decade, our medical communication services have helped pharmaceutical companies optimize their brand, disease and corporate objectives. Building...

Latest intelligence

NICE
Evolution or revolution: the latest review of NICE methods
By Leela Barham...
PRO
Integrating patient reported outcomes into clinical trials
How capturing the patient voice is unlocking medicines’ commercial potential...
Theodora Harold
A snapshot of Crescendo Biologics
PME talks to CEO Theodora Harold...

Infographics